What biologic and oral small molecule therapies have been evaluated for use in SLE
What biologic and oral small molecule therapies have been evaluated for use in SLE? Other biologics including TNF inhibitors, abatacept, epratuzumab, tabalumab, ocrelizumab, and tocilizumab have had mixed or negative results when used in SLE patients. Monoclonal antibodies against type I IFNs (e.g., IFNα) and the type I IFN receptor are currently under investigation but …
What biologic and oral small molecule therapies have been evaluated for use in SLE Read More »